Metagenomics Sequencing Market Scope
Metagenomics is the study of a microbial community's genomes as a whole. Cloning and studying genomes without cultivating organisms in the community is part of this procedure. The metagenomics technique has resulted in significant improvements in microbial ecology, evolution, and diversity, this activity is currently mostly carried out in many research labs. The expansion of the worldwide metagenomics sequencing market is mostly fuelled by reasons such as major applications of metagenomics in many industries, numerous initiatives and financing from government and corporate organizations for large-scale sequencing projects, and a decrease in sequencing costs.
The Metagenomics Sequencing market study is segmented, by Application (Infectious Disease Diagnosis, Environmental Remediation, Gut Microbe Characterization, Biofuel and Others) and major geographies with country level break-up.
Mergers and acquisitions, expansions, investments, new service launches, and collaborations are some of the companies' preferred market-exploration strategies. The company is contributing its share to increasing the company’s growth. The major key players like Illumina, Inc., Thermo Fisher Scientific, QIAGEN N.V., and PerkinElmer, Inc. are contributing their share to increasing the market growth.
Illumina, Inc. (United States), Thermo Fisher Scientific (United States), QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (United States), Oxford Nanopore Technologies Plc. (United States), BGI Genomics Co., Ltd. (China), Eurofins Genomics (Germany), Macrogen Inc. (South Korea), Pacific Biosciences of California, Inc. (United States) and Swift Biosciences Inc. (United States) are some of the key players that are part of study coverage.
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
AMA Research has segmented the market of Global Metagenomics Sequencing market by Type, Application and Region.
On the basis of geography, the market of Metagenomics Sequencing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
In Jan 2021, Illumina, Inc. (US) collaborated with Helix to strengthen national surveillance infrastructure in the US to track the emergence and prevalence of novel SARS-CoV-2 strains, with support from the CDC. and In July 2021, QIAGEN N.V. (Netherlands) and Sysmex Corporation have forged a strategic agreement for the development and marketing of worldwide cancer companion diagnostics using NGS and Plasma-Safe-SeqS technology.
- Availability of Cloud Computing for Data Management
- New Technology Innovation in NGS Platform
- Increasing Awareness Regarding Genetic Disorders
- Increasing Drug Manufactures In Developing Country
- Increasing R&D Activities to Identify New Antibiotics and Enzymes Products
- Lack of Skilled Professionals Are Required
- Budget Limits for End Users in Developing Nations
- Challenges Associated With Metagenomics NGS
- Strict Government Regulation in Market
Key Target AudienceIndustry Association, Downstream Vendors, Marketing & Consulting firms, Venture Capitalists, Government & Regulatory Bodies and Investors
Frequently Asked Questions (FAQ):
1. Is it possible to have certain customization in the study?
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.
2. How big is the Metagenomics Sequencing Market?
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2027.